A
Power Law company profile
Arrowhead Pharmaceuticals
Biotech & Life Sciences · Pasadena, United States · Founded 2003 Unicorn
Valuation
$9.27B
Market cap · Apr/2026
Revenue
$829M
Latest reported FY
Global footprint
Where Arrowhead Pharmaceuticals has talent and traffic
AI talent share
0.1%
of workforce is AI talent
(1 of 737 staff)
(1 of 737 staff)
Core AI00%
Other AI10.14%
Non-AI workforce73699.86%
Web traffic by country
56K
monthly visits
across markets
across markets
🇺🇸 United States62.5%
🇮🇳 India5.7%
🇨🇦 Canada4.6%
🇬🇧 United Kingdom4.6%
🏳️ Korea3.9%
Patent intelligence
$246M patent portfolio · 153 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$246M
2.7% of market cap · 1.7× the top peer SomaLogic ($141M)
153 active patent families
Where Arrowhead Pharmaceuticals innovates
Nucleic acidPolymerDiseaseCell biologyIn vivo
Tracks the peer median across all five Patsnap quality dimensions.
Quality vs same-sector peers
Arrowhead Pharmaceuticals on the five Patsnap quality dimensions
Arrowhead Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Arrowhead Pharmaceuticals concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Arrowhead Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Arrowhead Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.